Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
This selective mechanism produces metabolic safety benefits that may make AOD-9604 appropriate for individuals who cannot tolerate or have contraindications to conventional growth hormone therapy
Heres what you need to know: Mechanism: Stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) through beta-3 adrenergic receptor modulation and direct adipocyte interaction Primary Benefit: Enhanced fat metabolism and body composition improvement without affecting blood sugar or insulin sensitivity Administration: Subcutaneous injection or oral administration, typically daily Typical Dosing: 250-500 mcg daily via injection, or higher doses (1-2 mg) orally, administered in morning on empty stomach Results Timeline: Initial metabolic changes within 2-4 weeks, visible body composition changes in 8-12 weeks Best For: Individuals seeking metabolic support, stubborn fat reduction, and body recomposition without growth hormone effects Safety Profile: Clinical trials with over 900 participants demonstrated excellent tolerability with no serious adverse events Comparison: More selective than full-length growth hormone, targeting only fat metabolism without affecting glucose regulation or IGF-1 levels The following guide provides complete details on AOD-9604 s metabolic support process, from molecular mechanisms to practical protocols
Know More The neurotropic vitamins B1, B2, B6 and B12 are the unsung heroes of nerve health
High oral bioavailability and membrane permeability ensure effective systemic distribution without complex preparation requirements
It remains an investigational peptide used in clinical and research settings outside of formal FDA-approved indications
